Psoriasis: who works on it

One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.

EU-13 is a filter, not a ranking: it only narrows the list.

24 of 200+ institutions, ordered by recent publications and open trials. This is not a ranking of quality.

Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.

No stopped trial with a stated reason in this view.

Trials whose registry record says individual participant data (IPD) will be shared.

• A Long-term Extension Study of Ustekinumab in Pediatric Participants

  NCT05092269· Janssen Research & Development, LLC· Source

• A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis

  NCT07321873· Janssen Research & Development, LLC· Source

• A Study of Persistence to Guselkumab Treatment in Participants With Moderate-to-Severe Plaque Psoriasis in Romania

  NCT07582783· Janssen Research & Development, LLC· Source

• A Remotely Conducted Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically

  NCT07654751· Janssen Research & Development, LLC· Source

• A Safety Study of Ustekinumab in the Treatment of Pediatric Participants Aged 6 Years and Older With Moderate to Severe Plaque Psoriasis

  NCT03218488· Janssen-Cilag International NV· Source

• A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial Disease

  NCT04929210· Janssen Research & Development, LLC· Source

• A Study of Guselkumab Treatment Persistence in Psoriatic Arthritis Participants

  NCT07532226· Janssen-Cilag Ltd.· Source

• A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants

  NCT06663332· Janssen Research & Development, LLC· Source

• A Study to Evaluate the Efficacy and Safety of JNJ-77242113 (Icotrokinra) in Biologic-naïve Participants With Active Psoriatic Arthritis

  NCT06878404· Janssen Research & Development, LLC· Source

• A Study of Guselkumab in Participants With Psoriatic Arthritis (PsA) in a Real-World Setting

  NCT07220824· Janssen Research & Development, LLC· Source

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

• Mendelian Randomization Analysis 6
• Gene Expression Profiling 4
• Metabolomics 1
• Flow Cytometry 6
• Immunohistochemistry 14
• Positron-Emission Tomography 1
• Magnetic Resonance Imaging 4
• Machine Learning 2
• Cohort Studies 9
• Genome-Wide Association Study 2

See which targets of this disease your abstract mentions, and go to the people working on them.